To further examine this possibility, we generated a LATS1L 20-gene signature, comprising genes that were selectively down-regulated in LATS1-low human breast tumors (see Fig 1A) and evaluated its expression in different breast cancer subtypes. This evidence concerns the gene LATS1 and breast cancer.